High Tower Advisors, LLC Immuno Gen, Inc. Transaction History

High Tower Advisors, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$4.26 - $7.48 $45,637 - $80,133	-10,713 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$4.75 - $7.5 $50,886 - $80,347	10,713 New	10,713 $77,000
Q1 2021 May 10, 2021	SELL	$6.5 - $10.53 $68,562 - $111,070	-10,548 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$3.7 - $7.66 $3,496 - $7,238	-945 Reduced 8.22%	10,548 $62,000
Q3 2020 Nov 13, 2020	SELL	$3.45 - $4.89 $331,727 - $470,188	-96,153 Reduced 89.32%	11,493 $31,000
Q2 2020 Aug 10, 2020	BUY	$3.32 - $5.34 $357,384 - $574,829	107,646 New	107,646 $485,000
Q4 2019 Feb 14, 2020	SELL	$2.25 - $5.8 $27,060 - $69,756	-12,027 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$2.22 - $3.39 $1,751 - $2,674	789 Added 7.02%	12,027 $17,000
Q2 2019 Aug 13, 2019	BUY	$1.8 - $3.3 $20,228 - $37,085	11,238 New	11,238 $13,000
Q1 2019 May 15, 2019	SELL	$2.41 - $5.91 $24,794 - $60,802	-10,288 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.94 - $9.7 $40,534 - $99,793	10,288 New	10,288 $37,000
Q3 2018 Nov 09, 2018	SELL	$8.6 - $11.26 $93,370 - $122,249	-10,857 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$9.52 - $12.15 $4,541 - $5,795	-477 Reduced 4.21%	10,857 $104,000
Q1 2018 May 15, 2018	SELL	$6.7 - $12.95 $5,112 - $9,880	-763 Reduced 6.31%	11,334 $119,000
Q4 2017 Feb 14, 2018	SELL	$5.07 - $7.92 $5,693 - $8,894	-1,123 Reduced 8.49%	12,097 $74,000
Q3 2017 Nov 14, 2017	SELL	$5.4 - $8.47 $21,405 - $33,575	-3,964 Reduced 23.07%	13,220 $103,000
Q2 2017 Aug 14, 2017	BUY	N/A	17,184	17,184 $128,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.